Mycoplasma genitalium (Mgen) is a recognised sexually transmitted infection (STI) with clinical presentation similar to that of Chlamydia trachomatis (CT).

Key facts:

• M. genitalium is a leading cause of non-gonococcal urethritis in men (NGU)¹. In women, it has been associated with Pelvic Inflammatory Disease (PID), which can lead to tubal factor infertility, ectopic pregnancy, and chronic pelvis pain².
• Prevalence of Mgen can range from 1% – 4% in the general population and in higher risk populations can range from 9% – >50%, often exceeding that of Neisseria gonorrhoeae (NG) ³.
• Prevalence of Mgen in less developed countries can be 3 times higher than in developed territories³.
• Screening for Mgen using NAATs could lead to significant reductions in rates of PID in women due to Mgen, with cumulative incidence over 20 years reduced by 31.1%⁴.

---

Benefits of CT Mycoplasma genitalium:

• Highly sensitive assay
• Validated male and female urine and vaginal swabs
• No repeat testing – LAMP technology is characteristically tolerant of potentially inhibitory sample
• In combination with HG CT/NG Combo, one single urine or swab sample can test for three of the most common STIs – C. trachomatis (CT), N. gonorrhoeae (NG) and M. genitalium (Mgen)

---

---

Test information

Methodology:	Loop Mediated Isothermal Amplification (LAMP)
Target:	Mycoplasma genitalium
Sample types:	Urine and vaginal swabs
Hands-on time:	5 minutes
Sample to result:	66 minutes

---

Ordering Information

Product Name	# of Tests	Catalogue
HG MYG	30	HGMYGR
HG MYG Control	18	HGMYGC
HG Swift	–	HGSWIFT
Mini Heating Dry Bath Incubator	–	HGHEATB
Mini Centrifuge	–	HGCFUGE
Mini Vortex	–	HGVORTEX

---

References

1. PJ. Horner and DH. Martin,The Journal of Infectious Diseases, vol. 216, pp. 396-405, 2017.
2. HC. Wiesenfeld, and LE. Manhart. The Journal of Infectious Diseases, vol. 216, pp. 389-395, 2017
3. Baumann L, et al. Sex Transm Infect 2018;94:254–261
4. Birger, et al. Scientific Reports 7, 16162 (2017).